Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma

Table 2 Hepatocellular carcinoma therapy in the two groups

Method	Group A n = 212	Group B n = 136	P value
TACE, No. of times	483	269	0.043
RFA, No. of times	364	175	0.037

Minor differences (P < 0.05) could be seen in number of times of therapy for TACE and RFA between the two groups. RFA: Radiofrequency ablation; TACE: Transarterial chemoembolization.